The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Open accessAbstract
Accumulating evidence indicates that obesity is closely associated with an increased risk of metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and nonalcoholic fatty liver disease. Obesity results from an imbalance between food intake and energy expenditure, which leads to an excessive accumulation of adipose tissue. Adipose tissue is now recognized not only as a main site of storage of excess energy derived from food intake but also as an endocrine organ. The expansion of adipose tissue produces a number of bioactive substances, known as adipocytokines or adipokines, which trigger chronic low-grade inflammation and interact with a range of processes in many different organs. Although the precise mechanisms are still unclear, dysregulated production or secretion of these adipokines caused by excess adipose tissue and adipose tissue dysfunction can contribute to the development of obesity-related metabolic diseases. In this review, we focus on the role of several adipokines associated with obesity and the potential impact on obesity-related metabolic diseases. Multiple lines evidence provides valuable insights into the roles of adipokines in the development of obesity and its metabolic complications. Further research is still required to fully understand the mechanisms underlying the metabolic actions of a few newly identified adipokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedFriedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“many pro-inflammatory chemokines, cytokines and adipokines that are closely related to insulin resistance [5,6,40].”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“Along with the increased number of macrophages in adipose tissue, obesity induces a phenotypic switch in these cells from an anti-inflammatory M2 polarization state to a pro-inflammatory M1 polarization state [41].”
BackgroundAdipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Levesque, R. J. R. (2017) · Encyclopedia of Adolescence · doi:10.1007/978-3-319-32132-5_447-2 · Cited by 4,021
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Health and economic burden of the projected obesity trends in the USA and the UK
Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60814-3 · Cited by 2,692
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,160
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“In addition, free fatty acids are ligands of the membrane-bound TLR4 and can promote inflammation [24,28].”
BackgroundXu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.-L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2277 · Cited by 1,164 · cited 1×
“Furthermore, weight loss decreases macrophage infiltration and pro-inflammatory gene expression in adipose tissue in obese subjects [48,49].”
BackgroundWang, Y., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.555 · Cited by 1,123
The role of the novel adipocyte-derived hormone adiponectin in human disease
Diez, J., & Iglesias, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480293 · Cited by 1,114
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“macrophages [29], thereby modulating inflammation of adipose tissue which contributes to obesity-associated metabolic complications.”
BackgroundCloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Splanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Resistin is expressed in human macrophages and directly regulated by PPARγ activators
Patel, L., Buckels, A. C., Kinghorn, I. J., Murdock, P. R., Holbrook, J. D., Plumpton, C., Macphee, C. H., & Smith, S. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02841-3 · Cited by 922
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 917
Lumeng, C. N., DelProposto, J. B., Westcott, D. J., & Saltiel, A. R. (2008) · Diabetes · doi:10.2337/db08-0872 · Cited by 917
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Fatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“[19] have recently suggested that the link between circulating free fatty acid levels and insulin sensitivity in vivo is needed to further elucidate this complicated relationship.”
BackgroundInsulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Adiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.
Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., & Feingold, K. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118653 · Cited by 862
Boden, G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790
The perils of portliness: causes and consequences of visceral adiposity.
Montague, C. T., & O'Rahilly, S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.883 · Cited by 737
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · cited 1×
“Obesity-induced increases in lipolysis not only increases local extracellular lipid concentrations but also derives accumulation of macrophages in adipose tissue [64], which is associated with systemic hyperinsulinemia and insulin resistance in obese subjects [65].”
BackgroundRegulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
Plasma Visfatin Concentrations and Fat Depot–Specific mRNA Expression in Humans
Berndt, J., Klöting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schön, M. R., Stumvoll, M., & Blüher, M. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2911 · Cited by 724
The biology of white adipocyte proliferation
Hausman, D. B., DiGirolamo, M., Bartness, T. J., Hausman, G. J., & Martin, R. J. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00042.x · Cited by 707
Holland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Weight loss regulates inflammation‐related genes in white adipose tissue of obese subjects
ClÉment, K., Viguerie, N., Poitou, C., Carette, C., Pelloux, V., Curat, C. A., Sicard, A., Rome, S., Benis, A., Zucker, J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2204com · Cited by 640
Bastard, J.-P., Maachi, M., van Nhieu, J. T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.-J., Capeau, J., & Hainque, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8450 · Cited by 625
Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607
Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A. M., Paolisso, G., Marfella, R., & Giugliano, D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01741-2 · Cited by 555
Decreased Plasma Adiponectin Concentrations in Women with Dyslipidemia
Matsubara, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2764 · Cited by 544
Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α
Ruan, H., & Lodish, H. F. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00052-2 · Cited by 541
McArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
Impaired retinal function and vitamin A availability in mice lacking retinol‐binding protein
Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V., & Gottesman, M. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4633 · Cited by 506
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation
Massiéra, F., Bloch-Faure, M., Ceiler, D., Murakami, K., Fukamizu, A., Gasc, J.-M., Quignard-Boulangé, A., Negrel, R., Ailhaud, G., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., & Walsh, K. (2010) · Science · doi:10.1126/science.1188280 · Cited by 490
Interaction between glucose and free fatty acid metabolism in human skeletal muscle.
Kelley, D. E., Mokan, M., Simoneau, J. A., & Mandarino, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116603 · Cited by 481
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454
Leptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes
Müller, G., Ertl, J., Gerl, M., & Preibisch, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10585 · Cited by 450
Koteish, A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 445
The Adipocyte as an Endocrine Cell
Halberg, N., Wernstedt-Asterholm, I., & Scherer, P. E. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.002 · Cited by 442
Dressler, K. A., Mathias, S., & Kolesnick, R. N. (1992) · Science · doi:10.1126/science.1313189 · Cited by 440
Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 439
Adiponectin: a key adipocytokine in metabolic syndrome
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006) · Clinical Science · doi:10.1042/cs20050182 · Cited by 432
Santomauro, A. T., Boden, G., Silva, M. E., Rocha, D. M., Santos, R. F., Ursich, M. J., Strassmann, P. G., & Wajchenberg, B. L. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1836 · Cited by 431 · cited 1×
“The anti-lipolysis drug also decreased fasting plasma free fatty acids levels in lean control, obese nondiabetic, obese subjects with impaired glucose tolerance, and the lowering of plasma free fatty acids levels improved insulin resistance and glucose tolerance in obese subjects, regardless of the degree of their pre…”
BackgroundDeficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
Netea, M. G., Joosten, L. A. B., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J., van Krieken, H., Kim, S.-H., Stalenhoef, A. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1415 · Cited by 424
Resistin, central obesity, and type 2 diabetes
McTernan, C., McTernan, P., Harte, A., Levick, P., Barnett, A., & Kumar, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07281-1 · Cited by 423
St-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422
Heilbronn, L., Smith, S. R., & Ravussin, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802853 · Cited by 412
Adiponectin and its receptors in non-alcoholic steatohepatitis
Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C. F., Patsch, J. R., & Tilg, H. (2005) · Gut · doi:10.1136/gut.2003.037010 · Cited by 412
Crowl, R. M., Stoller, T. J., Conroy, R. R., & Stoner, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52293-6 · Cited by 409
Klöting, N., Graham, T. E., Berndt, J., Kralisch, S., Kovacs, P., Wason, C. J., Fasshauer, M., Schön, M. R., Stumvoll, M., Blüher, M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.002 · Cited by 406
Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
Roden, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0190 · Cited by 405
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E. B., Jones, K. L., Kawamori, R., Cassis, L. A., Tschöp, M. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31986 · Cited by 401
Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Ma, L.-J., Mao, S.-L., Taylor, K. L., Kanjanabuch, T., Guan, Y., Zhang, Y., Brown, N. J., Swift, L. L., McGuinness, O. P., Wasserman, D. H., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.2.336 · Cited by 397
Secretory factors from human adipose tissue and their functional role
Hauner, H. (2005) · Proceedings of the Nutrition Society · doi:10.1079/pns2005428 · Cited by 391
Apovian, C. M., Bigornia, S., Mott, M., Meyers, M. R., Ulloor, J., Gagua, M., McDonnell, M., Hess, D., Joseph, L., & Gokce, N. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.170316 · Cited by 386
Regional differences in cellular mechanisms of adipose tissue gain with overfeeding
Tchoukalova, Y. D., Votruba, S. B., Tchkonia, T., Giorgadze, N., Kirkland, J. L., & Jensen, M. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005259107 · Cited by 378
Schindhelm, R. K., Diamant, M., Dekker, J. M., Tushuizen, M. E., Teerlink, T., & Heine, R. J. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.666 · Cited by 375
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371 · cited 1×
“vascular cells, such as preadipocytes, fibroblasts, vascular endothelial cells, and a variety of immune cells, in adipose tissue, and its levels in plasma are increased in obesity and insulin resistance [128,129].”
BackgroundAdipocyte Lipases and Defect of Lipolysis in Human Obesity
Langin, D., Dicker, A., Tavernier, G., Hoffstedt, J., Mairal, A., Rydén, M., Arner, E., Sicard, A., Jenkins, C. M., Viguerie, N., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3190 · Cited by 370
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity
McQuaid, S. E., Hodson, L., Neville, M. J., Dennis, A. L., Cheeseman, J., Humphreys, S. M., Ruge, T., Gilbert, M., Fielding, B. A., Frayn, K. N., et al. (2011) · Diabetes · doi:10.2337/db10-0867 · Cited by 366
Tabata, M., Kadomatsu, T., Fukuhara, S., Miyata, K., Ito, Y., Endo, M., Urano, T., Zhu, H. J., Tsukano, H., Tazume, H., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.003 · Cited by 364
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Huber, J., Kiefer, F. W., Zeyda, M., Ludvik, B., Silberhumer, G. R., Prager, G., Zlabinger, G. J., & Stulnig, T. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2630 · Cited by 356
Yang, R.-Z., Lee, M.-J., Hu, H., Pollin, T. I., Ryan, A. S., Nicklas, B. J., Snitker, S., Horenstein, R. B., Hull, K., Goldberg, N. H., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030287 · Cited by 355
Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue
McTernan, P. G., McTernan, C. L., Chetty, R., Jenner, K., Fisher, F. M., Lauer, M. N., Crocker, J., Barnett, A. H., & Kumar, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2407 · Cited by 350
Adipose tissue-resident immune cells: key players in immunometabolism
Schipper, H. S., Prakken, B., Kalkhoven, E., & Boes, M. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.011 · Cited by 342
Studies of endotoxin-induced decrease in lipoprotein lipase activity.
Kawakami, M., & Cerami, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.631 · Cited by 327
Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324 · cited 1×
“Hyperglycemia results in increased IL-6 levels [97], and treatment with IL-6 induces hyperglycemia and insulin resistance in humans [98].”
BackgroundHaider, D. G., Schindler, K., Schaller, G., Prager, G., Wolzt, M., & Ludvik, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2248 · Cited by 303
Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G., & Vettor, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0361 · Cited by 295
Activation of SOCS-3 by Resistin
Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., & Lazar, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1569-1575.2005 · Cited by 281
Fain, J. N. (2010) · Mediators of Inflammation · doi:10.1155/2010/513948 · Cited by 280
Greenberg, A. S., Nordan, R. P., McIntosh, J. K., Calvo, J. C., Scow, R. O., & Jablons, D. M. (1992) · PubMed · Cited by 277
Dissection of the multiple mechanisms of TNF‐α‐induced apoptosis in liver injury
Ding, W., & Yin, X. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00469.x · Cited by 277
Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men
Skoog, T. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2805 · Cited by 275
Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats
Satoh, H., Nguyen, M. T., Miles, P. D. G., Imamura, T., Usui, I., & Olefsky, J. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420785 · Cited by 268
Jocken, J. W. E., Langin, D., Smit, E., Saris, W. H. M., Valle, C., Hul, G. B., Holm, C., Arner, P., & Blaak, E. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1318 · Cited by 264
Kakuma, T., Lee, Y., Higa, M., Wang, Z.-W., Pan, W., Shimomura, I., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8536 · Cited by 261
Rouzer, C. A., & Cerami, A. (1980) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(80)90046-8 · Cited by 258
Effects of Etanercept in Patients With the Metabolic Syndrome
Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.902 · Cited by 257
Weight loss reduces interleukin-18 levels in obese women
Esposito, K., Pontillo, A., Ciotola, M., Di Palo, C., Grella, E., Nicoletti, G., & Giugliano, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8781 · Cited by 254 · cited 1×
“Circulating IL-18 levels have been shown to be increased in obese subjects and reduced with weight loss [104].”
BackgroundKugiyama, K., Ota, Y., Takazoe, K., Moriyama, Y., Kawano, H., Miyao, Y., Sakamoto, T., Soejima, H., Ogawa, H., Doi, H., et al. (1999) · Circulation · doi:10.1161/01.cir.100.12.1280 · Cited by 249
Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell-Thompson, M., Crawford, J., Shek, E. W., Scarpace, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2333912100 · Cited by 247
Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 243
Benefits of lifestyle modification in NAFLD
Harrison, S. A., & Day, C. P. (2007) · Gut · doi:10.1136/gut.2006.112094 · Cited by 240
Balagopal, P., Graham, T. E., Kahn, B. B., Altomare, A., Funanage, V., & George, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2712 · Cited by 234
Qatanani, M., Szwergold, N. R., Greaves, D. R., Ahima, R. S., & Lazar, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37273 · Cited by 230
Teruel, T., Hernandez, R., & Lorenzo, M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2563 · Cited by 230
Osawa, H., Yamada, K., Onuma, H., Murakami, A., Ochi, M., Kawata, H., Nishimiya, T., Niiya, T., Shimizu, I., Nishida, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/424761 · Cited by 229
CCL5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue
Keophiphath, M., Rouault, C., Divoux, A., Clément, K., & Lacasa, D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197442 · Cited by 229
Large, V., Reynisdottir, S., Langin, D., Fredby, K., Klannemark, M., Holm, C., & Arner, P. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32429-9 · Cited by 228
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 225
Girousse, A., Tavernier, G., Valle, C., Moro, C., Mejhert, N., Dinel, A.-L., Houssier, M., Roussel, B., Besse-Patin, A., Combes, M., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001485 · Cited by 221
Yao-Borengasser, A., Varma, V., Bodles, A. M., Rasouli, N., Phanavanh, B., Lee, M.-J., Starks, T., Kern, L. M., Spencer, H. J., Rashidi, A. A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0816 · Cited by 216
Varma, V., Yao-Borengasser, A., Rasouli, N., Bodles, A. M., Phanavanh, B., Lee, M.-J., Starks, T., Kern, L. M., Spencer, H. J., McGehee, R. E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1303 · Cited by 215
Saxena, N. K., Titus, M. A., Ding, X., Floyd, J., Srinivasan, S., Sitaraman, S. V., & Anania, F. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1847fje · Cited by 212
Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications
Paz-Filho, G., Mastronardi, C., Franco, C. B., Wang, K. B., Wong, M.-L., & Licinio, J. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000900001 · Cited by 212
Meijer, K., de Vries, M., Al-Lahham, S., Bruinenberg, M., Weening, D., Dijkstra, M., Kloosterhuis, N., van der Leij, R. J., van der Want, H., Kroesen, B.-J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017154 · Cited by 207
Jovinge, S., Hamsten, A., Tornvall, P., Proudler, A., Båvenholm, P., Ericsson, C.-G., Godsland, I., de Faire, U., & Nilsson, J. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90203-7 · Cited by 194
Memon, R. A. (1993) · Endocrinology · doi:10.1210/en.132.5.2246 · Cited by 193
Wang, H. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2520 · Cited by 193
Pagano, C., Soardo, G., Pilon, C., Milocco, C., Basan, L., Milan, G., Donnini, D., Faggian, D., Mussap, M., Plebani, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1056 · Cited by 191
Stefan, N., Machicao, F., Staiger, H., Machann, J., Schick, F., Tschritter, O., Spieth, C., Weigert, C., Fritsche, A., Stumvoll, M., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1948-3 · Cited by 186
KAWAKAMI, M., MURASE, T., OGAMA, H., ISHIBASHI, S., MORI, N., TAKAKU, F., & SHIBATA, S. (1987) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a121917 · Cited by 183
Tumor Necrosis Factor Stimulates Hepatic Lipid Synthesis and Secretion*
FEINGOLD, K. R., SERIO, M. K., ADI, S., MOSER, A. H., & GRUNFELD, C. (1989) · Endocrinology · doi:10.1210/endo-124-5-2336 · Cited by 183
CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance
Chavey, C., Lazennec, G., Lagarrigue, S., Clapé, C., Iankova, I., Teyssier, J., Annicotte, J.-S., Schmidt, J., Mataki, C., Yamamoto, H., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.002 · Cited by 182
PPARα is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue
Lee, Y., Yu, X., Gonzales, F., Mangelsdorf, D. J., Wang, M.-Y., Richardson, C., Witters, L. A., & Unger, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182420899 · Cited by 181
Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G. W., Mandarino, L. J., Shulman, G. I., & DeFronzo, R. A. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3148 · Cited by 181
Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol
Ito, Y., Fujimura, M., Ohta, M., & Hirano, T. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.149559 · Cited by 181
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition
Poitou, C., Viguerie, N., Cancello, R., De Matteis, R., Cinti, S., Stich, V., Coussieu, C., Gauthier, E., Courtine, M., Zucker, J. D., et al. (2005) · Diabetologia · doi:10.1007/s00125-004-1654-6 · Cited by 180
The prevalence of nonalcoholic fatty liver disease in the Americas
López-Velázquez, J. A., Silva-Vidal, K. V., Ponciano-Rodríguez, G., Chávez-Tapia, N. C., Arrese, M., Uribe, M., & Méndez-Sánchez, N. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30879-8 · Cited by 178
Disruption of CXC Motif Chemokine Ligand-14 in Mice Ameliorates Obesity-induced Insulin Resistance
Nara, N., Nakayama, Y., Okamoto, S., Tamura, H., Kiyono, M., Muraoka, M., Tanaka, K., Taya, C., Shitara, H., Ishii, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700412200 · Cited by 176 · cited 1×
“Besides CCL2/MCP-1, several other chemokines such as CCL5, C-X-C motif chemokine ligand 5 (CXCL5) and CXCL14 are also involved in adipose tissue macrophage infiltration and obesity-induced insulin resistance [46,80,81].”
BackgroundChemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-κB
Tourniaire, F., Romier, B., Lee, J. H., Marcotorchino, J., Gouranton, E., Salles, J., Malezet‐Desmoulins, C., Astier, J., Darmon, P., Blouin, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066515 · Cited by 176
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice
O'Rourke, R. W., White, A. E., Metcalf, M. D., Winters, B. R., Diggs, B. S., Zhu, X., & Marks, D. L. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.018 · Cited by 174
Després, J. P., Ferland, M., Moorjani, S., Nadeau, A., Tremblay, A., Lupien, P. J., Thériault, G., & Bouchard, C. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.4.485 · Cited by 173
Cai, L., de Beer, M. C., de Beer, F. C., & van der Westhuyzen, D. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411555200 · Cited by 173
Resistin: molecular history and prognosis
Banerjee, R. R., & Lazar, M. A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0428-9 · Cited by 172
Effect of short-term fasting on lipid kinetics in lean and obese women
Horowitz, J. F., Coppack, S. W., Paramore, D. S., Cryer, P. E., Zhao, G., & Klein, S. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.2.e278 · Cited by 171
Role of leptin in the pancreatic β-cell: effects and signaling pathways
Marroquí, L., González, A., Ñeco, P., Caballero‐Garrido, E., Vieira, E. C., Ripoll, C., Nadal, Á., & Quesada, I. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0025 · Cited by 170
Plasma Angiotensinogen Concentrations in Obese Patients
Umemura, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00053-8 · Cited by 170
Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells
Cao, Q., Mak, K. M., Ren, C., & Lieber, C. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308351200 · Cited by 169
Gavi, S., Stuart, L. M., Kelly, P., Melendez, M. M., Mynarcik, D. C., Gelato, M. C., & McNurlan, M. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1815 · Cited by 168
Nonalcoholic Fatty Liver Disease
Pοlyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824587e0 · Cited by 167
Manco, M., Marcellini, M., Giannone, G., & Nobili, V. (2007) · American Journal of Clinical Pathology · doi:10.1309/6vj4dwgydu0xyj8q · Cited by 166
Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients
Miyazaki, Y., Pipek, R., Mandarino, L. J., & DeFronzo, R. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802187 · Cited by 166
Jonkers, I. J., Mohrschladt, M. F., Westendorp, R. G., van der Laarse, A., & Smelt, A. H. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01123-8 · Cited by 166
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
Matsuura, F., Oku, H., Koseki, M., Sandoval, J. C., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Masuda, D., Maeda, N., Tsujii, K., Ishigami, M., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.040 · Cited by 163
Di Gregorio, G. B., Hensley, L., Lu, T., Ranganathan, G., & Kern, P. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00189.2003 · Cited by 161
Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency
Qi, Y., Nie, Z., Lee, Y.-S., Singhal, N. S., Scherer, P. E., Lazar, M. A., & Ahima, R. S. (2006) · Diabetes · doi:10.2337/db05-0615 · Cited by 157
Adipose tissue recruitment of leukocytes
Anderson‐Baucum, E. K., Gutierrez, D. A., & Hasty, A. H. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283393867 · Cited by 156
Veilleux, A., Caron-Jobin, M., Noël, S., Laberge, P. Y., & Tchernof, A. (2011) · Diabetes · doi:10.2337/db10-1039 · Cited by 155
Plasminogen activator inhibitor-1 modulates adipocyte differentiation
Liang, X., Kanjanabuch, T., Mao, S.-L., Hao, C., Tang, Y., Declerck, P. J., Hasty, A. H., Wasserman, D. H., Fogo, A. B., & Ma, L.-J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00605.2004 · Cited by 155
Fain, J. N., Sacks, H. S., Buehrer, B. M., Bahouth, S. W., Garrett, E., Wolf, R. Y., Carter, R. A., Tichansky, D. S., & Madan, A. K. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803790 · Cited by 154
Feng, B., Jiao, P., Nie, Y., Kim, T., Jun, D., van Rooijen, N., Yang, Z., & Xu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024358 · Cited by 154
Cited by
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“In addition to these proinflammatory changes, adipocyte hypertrophy is associated with larger triglyceride stores, a higher lipolytic rate, and an atherogenic lipid profile: elevated concentrations of small dense low-density lipoprotein cholesterol, high concentrations of triglycerides, triglyceriderich remnants, very…”
BackgroundInfluentialAL-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9090430 · Cited by 741
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Antidiabetic Properties of Dietary Flavonoids: A Cellular Mechanism Review
Vinayagam, R., & Xu, B. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0057-7 · Cited by 597
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Metadata
- Authors
- Jung, U., & Choi, M.-S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-04-11
- Volume
- 15
- Issue
- 4
- Pages
- 6184-6223
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W1978804351
- Cited by
- 1,880
- References
- 278
- FWCI
- 80.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.